The % of CD3 (CD3+CD19-), the % of CD4 (CD3+CD4+), the % of CD8 (CD3+CD8+) and the % of CD19 (CD3-CD19+) subsets were determined within the total lymphocyte population (gate A = Lympho). For the B cell subsets, the % of CD24++CD38++ transitional B cells and the % of CD24+CD38+ naïve B cells were determined within the total lymphocyte population (gate A = Lympho). The % of IgD+CD27- naïve B cells, the % of IgD+CD27+ unswitched memory B cells and the % of IgD-CD27+ switched memory B cells, and the % of IgD+CD38+/hi activated B cells and the % of IgD-CD38+/low memory B cells were determined within the B cell subset (gate F = CD19+). For the NK cell subsets, the % of CD3-CD56+ NK lymphocytes and the % CD3+CD56+ NK-like lymphocytes were determin...
<p>FSc-SSc profile was used to distinguish lymphocytes, monocytes and granulocytes (A). Within the l...
<p>We identified T cells from total leukocytes as shown. We first selected singlets using forward sc...
<p>The gating strategy applied for mucosal mononuclear cells (MMC) and peripheral blood mononuclear ...
<p>a) Viable cells were gated based on negative expression of the fixable viability stain (FVS). Tru...
<p>Gated cells (selected cells) are purple, while non-gated cells (discarded cells) are blue or blac...
<p>(A) After gating for single cells in forward scatter area (FSC-A) versus height (FSC-H) and side ...
<p><b>A.</b> PBMC and <b>B.</b> MBC. Initial gating is performed from the SSC-A vs. FSC-A to determi...
<p>Representative gating strategy for the identification of CD56<sup>dim</sup> and CD56<sup>bright</...
<p>A) Forward Scatter vs Side Scatter B) CD3 versus CD4 within the lymphocyte gate C) FOXP3 versus C...
<p>The lymphocytes were identified as R1 based on their size and granularity flow cytometric feature...
(A) For panel 4, the first and second gates were the same as panel 2 (Fig 3), the third gate was on ...
<p>These plots represent the gating strategy used for flowcytometry analysis of blood samples; lymph...
<p>Live singlet lymphocytes were gated on. From this population, CD3<sup>-</sup>CD56<sup>dim</sup> N...
<p>These plots represent the gating strategy used for flowcytometry analysis of blood samples; A, ly...
Shown are gating strategies for the analysis of (A), human immune cell subsets (hCD45+CD3+: T cells,...
<p>FSc-SSc profile was used to distinguish lymphocytes, monocytes and granulocytes (A). Within the l...
<p>We identified T cells from total leukocytes as shown. We first selected singlets using forward sc...
<p>The gating strategy applied for mucosal mononuclear cells (MMC) and peripheral blood mononuclear ...
<p>a) Viable cells were gated based on negative expression of the fixable viability stain (FVS). Tru...
<p>Gated cells (selected cells) are purple, while non-gated cells (discarded cells) are blue or blac...
<p>(A) After gating for single cells in forward scatter area (FSC-A) versus height (FSC-H) and side ...
<p><b>A.</b> PBMC and <b>B.</b> MBC. Initial gating is performed from the SSC-A vs. FSC-A to determi...
<p>Representative gating strategy for the identification of CD56<sup>dim</sup> and CD56<sup>bright</...
<p>A) Forward Scatter vs Side Scatter B) CD3 versus CD4 within the lymphocyte gate C) FOXP3 versus C...
<p>The lymphocytes were identified as R1 based on their size and granularity flow cytometric feature...
(A) For panel 4, the first and second gates were the same as panel 2 (Fig 3), the third gate was on ...
<p>These plots represent the gating strategy used for flowcytometry analysis of blood samples; lymph...
<p>Live singlet lymphocytes were gated on. From this population, CD3<sup>-</sup>CD56<sup>dim</sup> N...
<p>These plots represent the gating strategy used for flowcytometry analysis of blood samples; A, ly...
Shown are gating strategies for the analysis of (A), human immune cell subsets (hCD45+CD3+: T cells,...
<p>FSc-SSc profile was used to distinguish lymphocytes, monocytes and granulocytes (A). Within the l...
<p>We identified T cells from total leukocytes as shown. We first selected singlets using forward sc...
<p>The gating strategy applied for mucosal mononuclear cells (MMC) and peripheral blood mononuclear ...